EARN vs JNJ · P/E 16, rev $15.5M vs P/E 17, rev $49.37B
Ellington Residential Mortgage (EARN) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Ellington Residential Mortgage (EARN) is a asset management company listed on NYSE.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported EARN revenue for 2025-03-31 was $15.5M. Net income was -$7.9M. Revenue was down 69.0% from 2024-12-31 to 2025-03-31. EARN currently screens at market cap $163.8M and trailing P/E 15.6.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
EARN currently screens at market cap $163.8M and trailing P/E 15.6. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the EARN and JNJ stock pages for the full models.
Not investment advice.